M2bio Sciences Inc WUHN:OTCPK

RT Quote | Exchange | USD
Last | 03/01/21 EST
0.91UNCH (UNCH)
52 week range
0.02 - 1.09

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.91
  • 52 Week High1.09
  • 52 Week High Date02/18/21
  • 52 Week Low0.02
  • 52 Week Low Date04/28/20
  • Market Cap46.97M
  • Shares Out51.61M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.84
  • 1 Year % Change2,743.75

RATIOS/PROFITABILITY

  • EPS (TTM)-0.34
  • P/E (TTM)-2.68
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)585,770.00
  • ROE (MRQ)-9.43%
  • Revenue (MRQ)80.38M
  • Gross Margin (MRQ)18.09%
  • Net Margin (MRQ)-12.29%
  • Debt To Equity (MRQ)110.68%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest M2bio Sciences Inc News

There is no recent news for this security.

Latest WUHN News From Our Partners

February 1, 2021

QUOTE FINDER

Profile

MORE
M2Bio Sciences Inc, formerly Wuhan General Group (China) Inc., is a nutraceutical biotechnology company. The Company through its subsidiary MJ MedTech Inc researches, develops and commercializes a range of cannabidiol (CBD)-based products under Dr. AnnaRx and Medspresso brands. In addition, the Company also researches and develops indications for psilocybin therapies that will help patients who suffer from addiction, mental illness, Alzheimer's and Parkinson's. Its Dr. AnnaRx...
Jeffrey Robinson
Chief Executive Officer
Address
Apartment No 12, 9 Park Road, Gardens
Cape Town, QC
8001
South Africa